Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
BJU International|January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancerChristopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
The Prostate|January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical ProstatectomyCarolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
Asian Journal of Urology|February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancerChrista Babst, Thomas Amiel, Tobias Maurer, et al.
Urologia Internationalis|January 19, 2016
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume CenterJonas Schiffmann, Alexander Haese, Jochen Lenz, et al.
European Urology|August 23, 2008
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy seriesHendrik Isbarn, Sascha A Ahyai, Felix K H Chun, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
The Prostate|July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancerMike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
World Journal of Urology|January 19, 2023
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?Gisa Mehring, Derya Tilki, Hans Heinzer, et al.
Urologic Oncology|June 12, 2018
Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissectionFelix Preisser, Sebastiano Nazzani, Marco Bandini, et al.
Clinical Genitourinary Cancer|August 6, 2024
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer PatientsMike Wenzel, Malin Lutz, Benedikt Hoeh, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
BJU International|January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancerChristopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
The Prostate|January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical ProstatectomyCarolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
Asian Journal of Urology|February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancerChrista Babst, Thomas Amiel, Tobias Maurer, et al.
Urologia Internationalis|January 19, 2016
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume CenterJonas Schiffmann, Alexander Haese, Jochen Lenz, et al.
European Urology|August 23, 2008
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy seriesHendrik Isbarn, Sascha A Ahyai, Felix K H Chun, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
The Prostate|July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancerMike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
World Journal of Urology|January 19, 2023
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?Gisa Mehring, Derya Tilki, Hans Heinzer, et al.
Urologic Oncology|June 12, 2018
Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissectionFelix Preisser, Sebastiano Nazzani, Marco Bandini, et al.
Clinical Genitourinary Cancer|August 6, 2024
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer PatientsMike Wenzel, Malin Lutz, Benedikt Hoeh, et al.
Pageof 21